CSBR vs FAST · P/E 16, rev $56.9M vs P/E 43, rev $7.55B
Champions Oncology Inc (CSBR) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the CSBR and FAST stock pages for the full models.
Not investment advice.